Barrington Research Maintains Outperform on HealthEquity, Lowers Price Target to $110

Benzinga Newsdesk www.benzinga.com Negative 94.8%

Neg 94.8% Neu 0% Pos 0%

Barrington Research analyst Alexander Paris maintains HealthEquity (NASDAQ:HQY) with a Outperform and lowers the price target from $125 to $110.